Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1967]

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award

Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )

Applications of chimaeric antigen receptor T-cells in leukaemia

Dr Carl June - University of Pennsylvania, Philadelphia, USA

Applications of chimaeric antigen receptor T-cells in leukaemia ( Dr Carl June - University of Pennsylvania, Philadelphia, USA )

Minimal residual disease in multiple myeloma

Dr Bruno Paiva - University Clinic of Navarra, Pamplona, Spain

Minimal residual disease in multiple myeloma ( Dr Bruno Paiva - University Clinic of Navarra, Pamplona, Spain )

Immunoconjugates address unmet needs in Hodgkin's lymphoma patients

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands

Immunoconjugates address unmet needs in Hodgkin's lymphoma patients ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )

EHA 2015: Expert opinions on new treatment standard in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry...

EHA 2015: Expert opinions on new treatment standard in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon )

Exploring "bad luck" - why do some patients develop myeloid leukaemia?

Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK

Exploring "bad luck" - why do some patients develop myeloid leukaemia? ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )

Genomic sequencing to find AML-causing mutations

Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK

Genomic sequencing to find AML-causing mutations ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )

The latest in multiple myeloma: a European and US perspective

Prof Paul Richardson and Prof Marivi Mateos

The latest in multiple myeloma: a European and US perspective ( Prof Paul Richardson and Prof Marivi Mateos )

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid...

Prof Susan Branford - Adelaide University Adelaide, Australia

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ( Prof Susan Branford - Adelaide University Adelaide, Australia )

Advances in the treatment and management of CLL

Prof Clemens Wendtner and Prof Peter Hillmen

Advances in the treatment and management of CLL ( Prof Clemens Wendtner and Prof Peter Hillmen )

Transplantation combined with novel agents optimal treatment for multiple...

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

Transplantation combined with novel agents optimal treatment for multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

Monoclonal antibodies and multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

Monoclonal antibodies and multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

More from ecancer